These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16144999)

  • 1. Regression of medial elastocalcinosis in rat aorta: a new vascular function for carbonic anhydrase.
    Essalihi R; Dao HH; Gilbert LA; Bouvet C; Semerjian Y; McKee MD; Moreau P
    Circulation; 2005 Sep; 112(11):1628-35. PubMed ID: 16144999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin?
    Essalihi R; Ouellette V; Dao HH; McKee MD; Moreau P
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S147-50. PubMed ID: 15838266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of amlodipine treatment on vascular elastocalcinosis and stiffness in a rat model of isolated systolic hypertension.
    Essalihi R; Zandvliet ML; Moreau S; Gilbert LA; Bouvet C; Lenoël C; Nekka F; McKee MD; Moreau P
    J Hypertens; 2007 Sep; 25(9):1879-86. PubMed ID: 17762652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteries.
    Liang F; Glascock CB; Schafer DL; Sandoval J; Cable L; Melvin L; Hartman JC; Pitts KR
    Can J Physiol Pharmacol; 2010 Aug; 88(8):840-9. PubMed ID: 20725142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new rat model of diabetic macrovascular complication.
    Bouvet C; Peeters W; Moreau S; DeBlois D; Moreau P
    Cardiovasc Res; 2007 Feb; 73(3):504-11. PubMed ID: 17145050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent.
    Dao HH; Lemay J; de Champlain J; deBlois D; Moreau P
    J Hypertens; 2001 Nov; 19(11):1965-73. PubMed ID: 11677361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin.
    Traupe T; D'Uscio LV; Muenter K; Morawietz H; Vetter W; Barton M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():13S-15S. PubMed ID: 12193045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension.
    Dao HH; Essalihi R; Graillon JF; Larivière R; De Champlain J; Moreau P
    J Hypertens; 2002 Aug; 20(8):1597-606. PubMed ID: 12172322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin ETA receptor blockade with darusentan increases sodium and potassium excretion in aging rats.
    Traupe T; Ortmann J; Haas E; Münter K; Parekh N; Hofmann-Lehmann R; Baumann K; Barton M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):456-62. PubMed ID: 16633090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism.
    Mitchell A; Lückebergfeld B; Bührmann S; Rushentsova U; Nürnberger J; Siffert W; Schäfers RF; Philipp T; Wenzel RR
    Clin Pharmacol Ther; 2004 Nov; 76(5):396-408. PubMed ID: 15536455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium, carbonic anhydrase and gastric acid secretion.
    Puscas I; Coltau M; Baican M; Domuta G; Hecht A
    Physiol Res; 2001; 50(4):359-64. PubMed ID: 11551141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for reactive oxygen species in arterial medial elastocalcinosis?
    Lalaoui MZ; El Midaoui A; de Champlain J; Moreau P
    Vascul Pharmacol; 2007 Mar; 46(3):201-6. PubMed ID: 17127099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic endothelin ET(A) receptor blockade on blood pressure and vascular formation of cyclic guanosine-3',5'-monophosphate in spontaneously hypertensive rats.
    Kirchengast M; Witte K; Stolpe K; Schilling L; Nedvetsky PI; Schmidt HH; Lemmer B
    Arzneimittelforschung; 2005; 55(9):498-504. PubMed ID: 16229113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction.
    Nguyen QT; Colombo F; Rouleau JL; Dupuis J; Calderone A
    Br J Pharmacol; 2000 Aug; 130(7):1525-30. PubMed ID: 10928953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of darusentan: a novel endothelin receptor antagonist.
    Epstein BJ
    Ann Pharmacother; 2008 Jul; 42(7):1060-9. PubMed ID: 18523233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation.
    Barton M; Shaw S; d'Uscio LV; Moreau P; Lüscher TF
    Biochem Biophys Res Commun; 1997 Sep; 238(3):861-5. PubMed ID: 9325182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-bound carbonic anhydrases in osteoclasts.
    Riihonen R; Supuran CT; Parkkila S; Pastorekova S; Väänänen HK; Laitala-Leinonen T
    Bone; 2007 Apr; 40(4):1021-31. PubMed ID: 17291844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
    Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-A receptor antagonist reduces microcirculatory disturbances and transplant dysfunction after partial liver transplantation.
    Palmes D; Budny TB; Stratmann U; Herbst H; Spiegel HU
    Liver Transpl; 2003 Sep; 9(9):929-39. PubMed ID: 12942454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.